R.PR
REGISTERED-PRINCIPAL REGISTER
08/03/2022
Voltar para busca
Dado oficial do USPTO
ARGORNA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
21/04/2023
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
23/01/2020
Data de registro
08/03/2022
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/03/2022
Última transação
21/04/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
22
Localização do titular
HUANGPU DISTRICT, GUANGZHOU, CN
Examinador
BATT, JAIME
Unidade examinadora
N70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
ARGORNA PHARMACEUTICALS LIMITED
GUANGZHOU RIBOBIO CO., LTD.
Representantes
Stacy L. Emhoff WALKER & JOCKE CO., LPA
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicines for human purposes for the treatment of tumorasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; Pharmaceutical preparations for the treatment of tumorasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; Chemical-pharmaceutical preparations for the treatment of tumorasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; Drug delivery agents in the form of sterile liquidsterile freeze-dry powderemulsion or inhalation for medical purposes that provide controlled release of active ingredients for the treatment of tumorasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; Veterinary preparations for the treatment of bird fluporcine reproductive and respiratory syndromerabiesdistemperheartworm in catsdogshorseschicken and pigs; Medicines for veterinary purposes being preparations for the treatment of bird fluporcine reproductive and respiratory syndromerabiesdistemperheartworm in catsdogshorseschicken and pigs; Biological preparations for veterinary purposes for the treatment of bird fluporcine reproductive and respiratory syndromerabiesdistemperheartworm; Chemical preparations for veterinary purposes for the treatment of bird fluporcine reproductive and respiratory syndromerabiesdistemperheartworm; Preparations for destroying noxious animalspesticidesinsecticides; Preparations for destroying noxious plantsherbicides
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/12/2021
PUBO
PUBLISHED FOR OPPOSITION
21/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/12/2021
OTHE
CASE RETURNED TO EXAMINATION
23/09/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
23/09/2021
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
23/09/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
20/09/2021
APET
ASSIGNED TO PETITION STAFF
14/09/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
07/09/2021
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
07/09/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/07/2021
EX2G
SOU EXTENSION 2 GRANTED
27/07/2021
EXT2
SOU EXTENSION 2 FILED
27/07/2021
EEXT
SOU TEAS EXTENSION RECEIVED
27/07/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/05/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27/01/2021
EX1G
SOU EXTENSION 1 GRANTED
25/01/2021
EXT1
SOU EXTENSION 1 FILED
25/01/2021
EEXT
SOU TEAS EXTENSION RECEIVED
25/01/2021
DOCK
ASSIGNED TO EXAMINER
12/01/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/06/2020
PUBO
PUBLISHED FOR OPPOSITION
09/06/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/05/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/04/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
20/04/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/04/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
20/04/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/04/2020
DOCK
ASSIGNED TO EXAMINER
13/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
27/01/2020
NWAP
NEW APPLICATION ENTERED
27/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ARGORNA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.